MarkEThompsonMD

PubMed

• 1 citations
  Oncology Payment Reform and Drug Reimbursement in the Proper Perspective
  Mark Thompson, Jeffrey Vacirca, Ted Okon
  Journal of Oncology Practice. 2015-03-03

Journal Articles

• Policy prescriptions to fix our ailing delivery system  
  Brow M, Okon T, Books B, Thompson M, Community Oncology, 12/1/2013
• Randomized Phase II Adjuvant Trial of Dose-Dense Docetaxel Before or After Doxorubicin Plus Cyclophosphamide in Axillary Node-Positive Breast Cancer  
  Puhalla S, Mrozek E, Young D, Ottman S, McVey A, Kendra K, Merriman N, Knapp M, Patel T, Thompson ME, Maher JF, Moore TD, Shapiro CL, J Clin Oncol, 1/1/2008
• Marked Hypoloidy in Blast Phase Chronic Myelogenous Leukemia: Report of a Case and Review of the Literature  
  Cibull M, Thompson M, Smith L, Jennings CD, Doukas M, Pavlik E, Powell D, American Journal of Hematology, 1/1/1987

Books/Book Chapters

• Support Care Cancer Care 
  Chapter: Antidepressant prescribing in community cancer care. 
  Page 278 - 285Ashbury FD, Madlensky L, Raich P, Thompson M, Whitney G, Hotz K, Kralj B, Edell W2003

Abstracts/Posters

• A single pegfilgrastim dose per cycle supports dose-dosedense (q14d) CHOP-R in patients with Non-Hodgkin's Lymphoma.
  Moore TD, Patel T, Segal ML, Zangmeister J, Chidiac TA, Roach RW, Thompson ME, Merriman N, Larrimer NR, Maher J, Christensen R, Ashbury FD, American Society of Hematology, San Diego, CA, 12/7/2003
• Integration of clinical trial decision rules in an electronic medical record (EMR) enhances patient accrual and facilitates data management, quality control and analysis.
  Moore TD, Hotz K, Christensen R, Litwak D, Meyer J, Baxter T, Thompson M, Ashbury FD, Proc Am Soc Clin Oncol, 1/1/2003
• A Single Pegfilgrastim Dose Per Cycle Supports Dose-Dense (q14d) CHOP-R in Patients with NHL.
  Moore T, Patel T, Segal M, Zangmeister J, Chidiac T, Roach R, Thompson M, Larrimer N, Journal of American Society of Hematology-Blood, 11/16/2002
• Use of quality indicators to improve medical oncology practice.
  Iverson DC, Ashbury FD, Thompson M, Dugan W, OpTx Corporation, Outcomes Group , Denver, USA, University of Colorado Health Sciences Center, Family Medicine, Denver, US..., European Cancer Conference, Lisbon, Portugal, 10/21/2001
• Infusional Interleukin-2 and 5-Fluorouracil with Subcutaneous Interferon-alpha for the Treatment of Patients with Advanced Renal Cell Carcinoma. (A Southwest Oncology ...
  Elias L, Lew D, Figlin RA, Flanigan RC, Thompson ME, Triozzi PL, Belt RJ, Wood, Jr. DP, Rivkin S, Crawford ED, Cancer, 1/1/2000
• Treatment of Non-Small Cell Carcinoma of Lung with Coumarin and Cimetidine.
  Marshall ME, Mendelsohn L, Butler K, Metcalf M, Thompson M, Harvey J, Cantrell J, MacDonald JS, Proceedings American Society of Clinical Oncology, 1/1/1986
• Join now to see all